Erica Stewart
Family Medicine · Junction City, KSNPI 1982197240
Payments from drug & device makers
Across 121 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$482
- Lilly USA, LLC$309
- AstraZeneca$173
- Novo Nordisk$167
- Astellas Pharma US Inc$165
- Amgen$60
- plus $572 from 21 others
What the payments were for
- Food & beverage$1,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $482 |
| Lilly USA, LLC | 17 | $309 |
| AstraZeneca | 6 | $173 |
| Novo Nordisk | 13 | $167 |
| Astellas Pharma US Inc | 7 | $165 |
| Amgen | 4 | $60 |
| Corium, LLC | 5 | $49 |
| Abbott | 2 | $46 |
| Pfizer | 3 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 1 | $36 |
| Novartis | 2 | $35 |
| Hologic Sales And Service, LLC | 2 | $31 |
| Merck | 2 | $31 |
| Cequr Corporation | 2 | $30 |
| Sumitomo Pharma America, Inc. | 2 | $27 |
| Johnson & Johnson | 2 | $27 |
| Insulet Corporation | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Recor Medical Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $17 |
| Organon | 3 | $17 |
| Boston Scientific | 1 | $15 |
| GSK | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Axsome Therapeutics, Inc. | 1 | $13 |
How this compares
$1,927 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 18 | $434 |
| Atorvastatin Calcium | 21 | $300 |
| Methylprednisolone | 33 | $194 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $143 |
| Azithromycin | 31 | $81 |
| Tramadol Hcl | 15 | $71 |
| Ciprofloxacin Hcl | 12 | $66 |
| Prednisone | 17 | $44 |
| Amlodipine Besylate | 14 | $37 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Junction City
- Scott AveryJunction City$195K
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.